Carvedilol Tablet, Film Coated
Product Images NDC 70518-2389

6 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 70518-2389). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Label for Carvedilol 25 mg film-coated tablets, containing 90 tablets. The label shows it is an oral human prescription drug repackaged by RemedyRepack Inc. It states the original manufacturer as Zydus Pharm, Pennington, NJ, with storage instructions and a QR code present on the label.*
FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 01)

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 01)
Chemical structure diagram of Carvedilol, showing its molecular composition including aromatic rings, hydroxyl groups, and other functional groups typical of this active ingredient.*
FDA Label Image

Carvedilol Tablets (B1fa8af3 9789 45d2 8b77 A53935c52b49 02)

Carvedilol Tablets (B1fa8af3 9789 45d2 8b77 A53935c52b49 02)
A line graph showing percent mortality over time in months, comparing two groups labeled Carvedilol and Placebo. The x-axis represents months up to 21, and the y-axis shows mortality percentage up to 30%. The graph includes a p-value of 0.0014 indicating statistical comparison between the groups.*
FDA Label Image

Carvedilol Tablets (B1fa8af3 9789 45d2 8b77 A53935c52b49 03)

Carvedilol Tablets (B1fa8af3 9789 45d2 8b77 A53935c52b49 03)
A forest plot displaying hazard ratios with confidence intervals for various patient subgroups, including gender, age, race, diabetic status, ischemic condition, heart rate, systolic blood pressure, and spironolactone usage. The plot visually compares risk across these groups with a reference line at hazard ratio 1.0.*
FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 04)

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 04)
A line graph comparing % mortality over 24 months between Carvedilol and placebo groups. The x-axis shows months from 0 to 24, and the y-axis shows mortality percentage from 0 to 30. The graph includes a significance value labeled P = 0.03.*
FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 05)

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 05)
A chart showing hazard ratio plots for different patient subgroups. The left and right panels display hazard ratios with confidence intervals for various conditions such as age, gender, myocardial infarction timing, use of beta-blockers, Killip class, thrombolytic therapy, PTCA, congestive heart failure status, angina, hypertension, diabetes, heart rate, and systolic blood pressure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.